APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Bio-based Hemostatic Powder

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Bio-based Hemostatic Powder Industry Growth and Trends Forecast to 2032

Report ID 173898230126 December 2025103 pages

Choose your research edition.

Industry ResearchBio-based Hemostatic Powder Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Bio-based Hemostatic Powder Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Bio-based Hemostatic Powder Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bio-based Hemostatic Powder Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Bio-based Hemostatic Powder Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Bio-based Hemostatic Powder market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Bio-based Hemostatic Powder is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Bio-based Hemostatic Powder is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bio-based Hemostatic Powder is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Bio-based Hemostatic Powder include BD, Lanhine Medical, Yancheng Yankang Medical Equipment, Success Bio-Tech, Johnson & Johnson, Haiyuan Hairun, Beijing Aitekang Medical Technology, Baxter and Medtronic, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Bio-based Hemostatic Powder market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Bio-based Hemostatic Powder market size, estimates, and forecasts are presented in terms of sales volume (Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Bio-based Hemostatic Powder market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Bio-based Hemostatic Powder.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Bio-based Hemostatic Powder market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Bio-based Hemostatic Powder Market by Company

BD

Lanhine Medical

Yancheng Yankang Medical Equipment

Success Bio-Tech

Johnson & Johnson

Haiyuan Hairun

Beijing Aitekang Medical Technology

Baxter

Medtronic

MedTrade Products

Hemostasis

BioCer Entwicklungs-GmbH

Bio-based Hemostatic Powder Segment by Type

Oxidized Cellulose

Polysaccharides

Other

Bio-based Hemostatic Powder Segment by Application

Surgery

First Aid

Bio-based Hemostatic Powder Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bio-based Hemostatic Powder market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bio-based Hemostatic Powder and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bio-based Hemostatic Powder.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Bio-based Hemostatic Powder manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Bio-based Hemostatic Powder in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Oxidized Cellulose Table 2. Major Company of Polysaccharides Table 3. Major Company of Other Table 4. Global Bio-based Hemostatic Powder Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Bio-based Hemostatic Powder Sales by Type (2021-2026) & (Units) Table 6. Global Bio-based Hemostatic Powder Sales Market Share in Volume by Type (2021-2026) Table 7. Global Bio-based Hemostatic Powder Sales by Type (2021-2026) & (US$ Million) Table 8. Global Bio-based Hemostatic Powder Sales Market Share in Value by Type (2021-2026) Table 9. Global Bio-based Hemostatic Powder Price by Type (2021-2026) & (US$/Unit) Table 10. Global Bio-based Hemostatic Powder Sales by Type (2027-2032) & (Units) Table 11. Global Bio-based Hemostatic Powder Sales Market Share in Volume by Type (2027-2032) Table 12. Global Bio-based Hemostatic Powder Sales by Type (2027-2032) & (US$ Million) Table 13. Global Bio-based Hemostatic Powder Sales Market Share in Value by Type (2027-2032) Table 14. Global Bio-based Hemostatic Powder Price by Type (2027-2032) & (US$/Unit) Table 15. North America Bio-based Hemostatic Powder Sales by Type (2021-2026) & (Units) Table 16. North America Bio-based Hemostatic Powder Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Bio-based Hemostatic Powder Sales by Type (2021-2026) & (Units) Table 18. Europe Bio-based Hemostatic Powder Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Bio-based Hemostatic Powder Sales by Type (2021-2026) & (Units) Table 20. Asia-Pacific Bio-based Hemostatic Powder Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Bio-based Hemostatic Powder Sales by Type (2021-2026) & (Units) Table 22. Latin America Bio-based Hemostatic Powder Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Bio-based Hemostatic Powder Sales by Type (2021-2026) & (Units) Table 24. Middle East and Africa Bio-based Hemostatic Powder Sales by Type (2021-2026) & (US$ Million) Table 25. Bio-based Hemostatic Powder Industry Trends Table 26. Bio-based Hemostatic Powder Industry Drivers Table 27. Bio-based Hemostatic Powder Industry Opportunities and Challenges Table 28. Bio-based Hemostatic Powder Industry Restraints Table 29. Global Bio-based Hemostatic Powder Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Bio-based Hemostatic Powder Revenue Market Share by Company (2021-2026) Table 31. Global Bio-based Hemostatic Powder Sales by Company (2021-2026) & (Units) Table 32. Global Bio-based Hemostatic Powder Sales Share by Company (2021-2026) Table 33. Global Bio-based Hemostatic Powder Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Bio-based Hemostatic Powder Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Bio-based Hemostatic Powder Major Company Production Sites and Headquarters Table 36. Global Bio-based Hemostatic Powder Company, Product Type & Application Table 37. Global Bio-based Hemostatic Powder Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Bio-based Hemostatic Powder by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Bio-based Hemostatic Powder Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Bio-based Hemostatic Powder Sales by Region (2021-2026) & (Units) Table 42. Global Bio-based Hemostatic Powder Sales Market Share in Volume by Region (2021-2026) Table 43. Global Bio-based Hemostatic Powder Sales by Region (2021-2026) & (US$ Million) Table 44. Global Bio-based Hemostatic Powder Sales Market Share in Value by Region (2021-2026) Table 45. Global Bio-based Hemostatic Powder Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Bio-based Hemostatic Powder Sales by Region (2027-2032) & (Units) Table 47. Global Bio-based Hemostatic Powder Sales Market Share in Volume by Region (2027-2032) Table 48. Global Bio-based Hemostatic Powder Sales by Region (2027-2032) & (US$ Million) Table 49. Global Bio-based Hemostatic Powder Sales Market Share in Value by Region (2027-2032) Table 50. Global Bio-based Hemostatic Powder Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Bio-based Hemostatic Powder Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Bio-based Hemostatic Powder Sales by Application (2021-2026) & (Units) Table 53. Global Bio-based Hemostatic Powder Sales Market Share in Volume by Application (2021-2026) Table 54. Global Bio-based Hemostatic Powder Sales by Application (2021-2026) & (US$ Million) Table 55. Global Bio-based Hemostatic Powder Sales Market Share in Value by Application (2021-2026) Table 56. Global Bio-based Hemostatic Powder Price by Application (2021-2026) & (US$/Unit) Table 57. Global Bio-based Hemostatic Powder Sales by Application (2027-2032) & (Units) Table 58. Global Bio-based Hemostatic Powder Sales Market Share in Volume by Application (2027-2032) Table 59. Global Bio-based Hemostatic Powder Sales by Application (2027-2032) & (US$ Million) Table 60. Global Bio-based Hemostatic Powder Sales Market Share in Value by Application (2027-2032) Table 61. Global Bio-based Hemostatic Powder Price by Application (2027-2032) & (US$/Unit) Table 62. North America Bio-based Hemostatic Powder Sales by Application (2021-2026) & (Units) Table 63. North America Bio-based Hemostatic Powder Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Bio-based Hemostatic Powder Sales by Application (2021-2026) & (Units) Table 65. Europe Bio-based Hemostatic Powder Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Bio-based Hemostatic Powder Sales by Application (2021-2026) & (Units) Table 67. Asia-Pacific Bio-based Hemostatic Powder Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Bio-based Hemostatic Powder Sales by Application (2021-2026) & (Units) Table 69. Latin America Bio-based Hemostatic Powder Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Bio-based Hemostatic Powder Sales by Application (2021-2026) & (Units) Table 71. Middle East and Africa Bio-based Hemostatic Powder Sales by Application (2021-2026) & (US$ Million) Table 72. BD Company Information Table 73. BD Business Overview Table 74. BD Bio-based Hemostatic Powder Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. BD Bio-based Hemostatic Powder Product Portfolio Table 76. BD Recent Development Table 77. Lanhine Medical Company Information Table 78. Lanhine Medical Business Overview Table 79. Lanhine Medical Bio-based Hemostatic Powder Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Lanhine Medical Bio-based Hemostatic Powder Product Portfolio Table 81. Lanhine Medical Recent Development Table 82. Yancheng Yankang Medical Equipment Company Information Table 83. Yancheng Yankang Medical Equipment Business Overview Table 84. Yancheng Yankang Medical Equipment Bio-based Hemostatic Powder Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Yancheng Yankang Medical Equipment Bio-based Hemostatic Powder Product Portfolio Table 86. Yancheng Yankang Medical Equipment Recent Development Table 87. Success Bio-Tech Company Information Table 88. Success Bio-Tech Business Overview Table 89. Success Bio-Tech Bio-based Hemostatic Powder Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Success Bio-Tech Bio-based Hemostatic Powder Product Portfolio Table 91. Success Bio-Tech Recent Development Table 92. Johnson & Johnson Company Information Table 93. Johnson & Johnson Business Overview Table 94. Johnson & Johnson Bio-based Hemostatic Powder Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Johnson & Johnson Bio-based Hemostatic Powder Product Portfolio Table 96. Johnson & Johnson Recent Development Table 97. Haiyuan Hairun Company Information Table 98. Haiyuan Hairun Business Overview Table 99. Haiyuan Hairun Bio-based Hemostatic Powder Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Haiyuan Hairun Bio-based Hemostatic Powder Product Portfolio Table 101. Haiyuan Hairun Recent Development Table 102. Beijing Aitekang Medical Technology Company Information Table 103. Beijing Aitekang Medical Technology Business Overview Table 104. Beijing Aitekang Medical Technology Bio-based Hemostatic Powder Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Beijing Aitekang Medical Technology Bio-based Hemostatic Powder Product Portfolio Table 106. Beijing Aitekang Medical Technology Recent Development Table 107. Baxter Company Information Table 108. Baxter Business Overview Table 109. Baxter Bio-based Hemostatic Powder Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Baxter Bio-based Hemostatic Powder Product Portfolio Table 111. Baxter Recent Development Table 112. Medtronic Company Information Table 113. Medtronic Business Overview Table 114. Medtronic Bio-based Hemostatic Powder Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Medtronic Bio-based Hemostatic Powder Product Portfolio Table 116. Medtronic Recent Development Table 117. MedTrade Products Company Information Table 118. MedTrade Products Business Overview Table 119. MedTrade Products Bio-based Hemostatic Powder Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. MedTrade Products Bio-based Hemostatic Powder Product Portfolio Table 121. MedTrade Products Recent Development Table 122. Hemostasis Company Information Table 123. Hemostasis Business Overview Table 124. Hemostasis Bio-based Hemostatic Powder Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Hemostasis Bio-based Hemostatic Powder Product Portfolio Table 126. Hemostasis Recent Development Table 127. BioCer Entwicklungs-GmbH Company Information Table 128. BioCer Entwicklungs-GmbH Business Overview Table 129. BioCer Entwicklungs-GmbH Bio-based Hemostatic Powder Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. BioCer Entwicklungs-GmbH Bio-based Hemostatic Powder Product Portfolio Table 131. BioCer Entwicklungs-GmbH Recent Development Table 132. North America Bio-based Hemostatic Powder Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 133. North America Bio-based Hemostatic Powder Sales by Country (2021-2026) & (Units) Table 134. North America Bio-based Hemostatic Powder Sales Market Share by Country (2021-2026) Table 135. North America Bio-based Hemostatic Powder Sales Forecast by Country (2027-2032) & (Units) Table 136. North America Bio-based Hemostatic Powder Sales Market Share Forecast by Country (2027-2032) Table 137. North America Bio-based Hemostatic Powder Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. North America Bio-based Hemostatic Powder Market Size by Country (2021-2026) & (US$ Million) Table 139. North America Bio-based Hemostatic Powder Market Share by Country (2021-2026) Table 140. North America Bio-based Hemostatic Powder Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. North America Bio-based Hemostatic Powder Market Share Forecast by Country (2027-2032) Table 142. Europe Bio-based Hemostatic Powder Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 143. Europe Bio-based Hemostatic Powder Sales by Country (2021-2026) & (Units) Table 144. Europe Bio-based Hemostatic Powder Sales Market Share by Country (2021-2026) Table 145. Europe Bio-based Hemostatic Powder Sales Forecast by Country (2027-2032) & (Units) Table 146. Europe Bio-based Hemostatic Powder Sales Market Share Forecast by Country (2027-2032) Table 147. Europe Bio-based Hemostatic Powder Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Europe Bio-based Hemostatic Powder Market Size by Country (2021-2026) & (US$ Million) Table 149. Europe Bio-based Hemostatic Powder Market Share by Country (2021-2026) Table 150. Europe Bio-based Hemostatic Powder Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Europe Bio-based Hemostatic Powder Market Share Forecast by Country (2027-2032) Table 152. Asia-Pacific Bio-based Hemostatic Powder Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 153. Asia-Pacific Bio-based Hemostatic Powder Sales by Country (2021-2026) & (Units) Table 154. Asia-Pacific Bio-based Hemostatic Powder Sales Market Share by Country (2021-2026) Table 155. Asia-Pacific Bio-based Hemostatic Powder Sales Forecast by Country (2027-2032) & (Units) Table 156. Asia-Pacific Bio-based Hemostatic Powder Sales Market Share Forecast by Country (2027-2032) Table 157. Asia-Pacific Bio-based Hemostatic Powder Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Asia-Pacific Bio-based Hemostatic Powder Market Size by Country (2021-2026) & (US$ Million) Table 159. Asia-Pacific Bio-based Hemostatic Powder Market Share by Country (2021-2026) Table 160. Asia-Pacific Bio-based Hemostatic Powder Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Asia-Pacific Bio-based Hemostatic Powder Market Share Forecast by Country (2027-2032) Table 162. Latin America Bio-based Hemostatic Powder Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 163. Latin America Bio-based Hemostatic Powder Sales by Country (2021-2026) & (Units) Table 164. Latin America Bio-based Hemostatic Powder Sales Market Share by Country (2021-2026) Table 165. Latin America Bio-based Hemostatic Powder Sales Forecast by Country (2027-2032) & (Units) Table 166. Latin America Bio-based Hemostatic Powder Sales Market Share Forecast by Country (2027-2032) Table 167. Latin America Bio-based Hemostatic Powder Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Latin America Bio-based Hemostatic Powder Market Size by Country (2021-2026) & (US$ Million) Table 169. Latin America Bio-based Hemostatic Powder Market Share by Country (2021-2026) Table 170. Latin America Bio-based Hemostatic Powder Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Latin America Bio-based Hemostatic Powder Market Share Forecast by Country (2027-2032) Table 172. Middle East and Africa Bio-based Hemostatic Powder Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 173. Middle East and Africa Bio-based Hemostatic Powder Sales by Country (2021-2026) & (Units) Table 174. Middle East and Africa Bio-based Hemostatic Powder Sales Market Share by Country (2021-2026) Table 175. Middle East and Africa Bio-based Hemostatic Powder Sales Forecast by Country (2027-2032) & (Units) Table 176. Middle East and Africa Bio-based Hemostatic Powder Sales Market Share Forecast by Country (2027-2032) Table 177. Middle East and Africa Bio-based Hemostatic Powder Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Middle East and Africa Bio-based Hemostatic Powder Market Size by Country (2021-2026) & (US$ Million) Table 179. Middle East and Africa Bio-based Hemostatic Powder Market Share by Country (2021-2026) Table 180. Middle East and Africa Bio-based Hemostatic Powder Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Middle East and Africa Bio-based Hemostatic Powder Market Share Forecast by Country (2027-2032) Table 182. Key Raw Materials Table 183. Raw Materials Key Suppliers Table 184. Bio-based Hemostatic Powder Distributors List Table 185. Bio-based Hemostatic Powder Customers List Table 186. Research Programs/Design for This Report Table 187. Authors List of This Report Table 188. Secondary Sources Table 189. Primary Sources List of Figures Figure 1. Bio-based Hemostatic Powder Image Figure 2. Global Bio-based Hemostatic Powder Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bio-based Hemostatic Powder Market Size (2021-2032) & (US$ Million) Figure 4. Global Bio-based Hemostatic Powder Sales (2021-2032) & (Units) Figure 5. Oxidized Cellulose Image Figure 6. Global Oxidized Cellulose Sales YoY Growth (2021-2032) & (Units) Figure 7. Polysaccharides Image Figure 8. Global Polysaccharides Sales YoY Growth (2021-2032) & (Units) Figure 9. Other Image Figure 10. Global Other Sales YoY Growth (2021-2032) & (Units) Figure 11. Global Bio-based Hemostatic Powder Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Bio-based Hemostatic Powder Market Share by Type 2025 VS 2032 Figure 13. North America Bio-based Hemostatic Powder Sales Market Share in Volume by Type in 2025 Figure 14. North America Bio-based Hemostatic Powder Sales Market Share in Value by Type in 2025 Figure 15. Europe Bio-based Hemostatic Powder Sales Market Share in Volume by Type in 2025 Figure 16. Europe Bio-based Hemostatic Powder Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Bio-based Hemostatic Powder Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Bio-based Hemostatic Powder Sales Market Share in Value by Type in 2025 Figure 19. Latin America Bio-based Hemostatic Powder Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Bio-based Hemostatic Powder Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Bio-based Hemostatic Powder Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Bio-based Hemostatic Powder Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Bio-based Hemostatic Powder Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Surgery Image Figure 26. Global Surgery Sales YoY Growth (2021-2032) & (Units) Figure 27. First Aid Image Figure 28. Global First Aid Sales YoY Growth (2021-2032) & (Units) Figure 29. Global Bio-based Hemostatic Powder Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Bio-based Hemostatic Powder Market Share by Application 2025 VS 2032 Figure 31. North America Bio-based Hemostatic Powder Sales Market Share in Volume by Application in 2025 Figure 32. North America Bio-based Hemostatic Powder Sales Market Share in Value by Application in 2025 Figure 33. Europe Bio-based Hemostatic Powder Sales Market Share in Volume by Application in 2025 Figure 34. Europe Bio-based Hemostatic Powder Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Bio-based Hemostatic Powder Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Bio-based Hemostatic Powder Sales Market Share in Value by Application in 2025 Figure 37. Latin America Bio-based Hemostatic Powder Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Bio-based Hemostatic Powder Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Bio-based Hemostatic Powder Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Bio-based Hemostatic Powder Sales Market Share in Value by Application in 2025 Figure 41. North America Bio-based Hemostatic Powder Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 42. North America Bio-based Hemostatic Powder Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Bio-based Hemostatic Powder Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Bio-based Hemostatic Powder Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Bio-based Hemostatic Powder Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 46. Europe Bio-based Hemostatic Powder Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Bio-based Hemostatic Powder Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Bio-based Hemostatic Powder Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Bio-based Hemostatic Powder Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 50. Asia-Pacific Bio-based Hemostatic Powder Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Bio-based Hemostatic Powder Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Bio-based Hemostatic Powder Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Bio-based Hemostatic Powder Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 54. Latin America Bio-based Hemostatic Powder Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Bio-based Hemostatic Powder Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Bio-based Hemostatic Powder Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Bio-based Hemostatic Powder Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 58. Middle East and Africa Bio-based Hemostatic Powder Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Bio-based Hemostatic Powder Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Bio-based Hemostatic Powder Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Bio-based Hemostatic Powder Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Bio-based Hemostatic Powder Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Oxidized Cellulose
  • Polysaccharides
  • Other
Applications
  • Surgery
  • First Aid
Companies covered
  • BD
  • Lanhine Medical
  • Yancheng Yankang Medical Equipment
  • Success Bio-Tech
  • Johnson & Johnson
  • Haiyuan Hairun
  • Beijing Aitekang Medical Technology
  • Baxter
  • Medtronic
  • MedTrade Products
  • Hemostasis
  • BioCer Entwicklungs-GmbH

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Bio-based Hemostatic Powder Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Bio-based Hemostatic Powder Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Bio-based Hemostatic Powder Market by Type
  6. 1.3.1 Oxidized Cellulose
  7. 1.3.2 Polysaccharides
  8. 1.3.3 Other
  9. 1.4 Global Bio-based Hemostatic Powder Market Size by Type
  10. 1.4.1 Global Bio-based Hemostatic Powder Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Bio-based Hemostatic Powder Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Bio-based Hemostatic Powder Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Bio-based Hemostatic Powder Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Bio-based Hemostatic Powder Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Bio-based Hemostatic Powder Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Bio-based Hemostatic Powder Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Bio-based Hemostatic Powder Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Bio-based Hemostatic Powder Industry Trends
  2. 2.2 Bio-based Hemostatic Powder Industry Drivers
  3. 2.3 Bio-based Hemostatic Powder Industry Opportunities and Challenges
  4. 2.4 Bio-based Hemostatic Powder Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Bio-based Hemostatic Powder Revenue (2021-2026)
  2. 3.2 Global Top Players by Bio-based Hemostatic Powder Sales (2021-2026)
  3. 3.3 Global Top Players by Bio-based Hemostatic Powder Price (2021-2026)
  4. 3.4 Global Bio-based Hemostatic Powder Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Bio-based Hemostatic Powder Major Company Production Sites & Headquarters
  6. 3.6 Global Bio-based Hemostatic Powder Company, Product Type & Application
  7. 3.7 Global Bio-based Hemostatic Powder Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Bio-based Hemostatic Powder Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Bio-based Hemostatic Powder Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Bio-based Hemostatic Powder Tier 1, Tier 2, and Tier 3
4 Bio-based Hemostatic Powder Regional Status and Outlook
  1. 4.1 Global Bio-based Hemostatic Powder Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Bio-based Hemostatic Powder Historic Market Size by Region
  3. 4.2.1 Global Bio-based Hemostatic Powder Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Bio-based Hemostatic Powder Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Bio-based Hemostatic Powder Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Bio-based Hemostatic Powder Forecasted Market Size by Region
  7. 4.3.1 Global Bio-based Hemostatic Powder Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Bio-based Hemostatic Powder Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Bio-based Hemostatic Powder Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Bio-based Hemostatic Powder by Application
  1. 5.1 Bio-based Hemostatic Powder Market by Application
  2. 5.1.1 Surgery
  3. 5.1.2 First Aid
  4. 5.2 Global Bio-based Hemostatic Powder Market Size by Application
  5. 5.2.1 Global Bio-based Hemostatic Powder Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Bio-based Hemostatic Powder Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Bio-based Hemostatic Powder Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Bio-based Hemostatic Powder Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Bio-based Hemostatic Powder Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Bio-based Hemostatic Powder Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Bio-based Hemostatic Powder Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Bio-based Hemostatic Powder Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 BD
  2. 6.1.1 BD Company Information
  3. 6.1.2 BD Business Overview
  4. 6.1.3 BD Bio-based Hemostatic Powder Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 BD Bio-based Hemostatic Powder Product Portfolio
  6. 6.1.5 BD Recent Developments
  7. 6.2 Lanhine Medical
  8. 6.2.1 Lanhine Medical Company Information
  9. 6.2.2 Lanhine Medical Business Overview
  10. 6.2.3 Lanhine Medical Bio-based Hemostatic Powder Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Lanhine Medical Bio-based Hemostatic Powder Product Portfolio
  12. 6.2.5 Lanhine Medical Recent Developments
  13. 6.3 Yancheng Yankang Medical Equipment
  14. 6.3.1 Yancheng Yankang Medical Equipment Company Information
  15. 6.3.2 Yancheng Yankang Medical Equipment Business Overview
  16. 6.3.3 Yancheng Yankang Medical Equipment Bio-based Hemostatic Powder Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Yancheng Yankang Medical Equipment Bio-based Hemostatic Powder Product Portfolio
  18. 6.3.5 Yancheng Yankang Medical Equipment Recent Developments
  19. 6.4 Success Bio-Tech
  20. 6.4.1 Success Bio-Tech Company Information
  21. 6.4.2 Success Bio-Tech Business Overview
  22. 6.4.3 Success Bio-Tech Bio-based Hemostatic Powder Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Success Bio-Tech Bio-based Hemostatic Powder Product Portfolio
  24. 6.4.5 Success Bio-Tech Recent Developments
  25. 6.5 Johnson & Johnson
  26. 6.5.1 Johnson & Johnson Company Information
  27. 6.5.2 Johnson & Johnson Business Overview
  28. 6.5.3 Johnson & Johnson Bio-based Hemostatic Powder Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Johnson & Johnson Bio-based Hemostatic Powder Product Portfolio
  30. 6.5.5 Johnson & Johnson Recent Developments
  31. 6.6 Haiyuan Hairun
  32. 6.6.1 Haiyuan Hairun Company Information
  33. 6.6.2 Haiyuan Hairun Business Overview
  34. 6.6.3 Haiyuan Hairun Bio-based Hemostatic Powder Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Haiyuan Hairun Bio-based Hemostatic Powder Product Portfolio
  36. 6.6.5 Haiyuan Hairun Recent Developments
  37. 6.7 Beijing Aitekang Medical Technology
  38. 6.7.1 Beijing Aitekang Medical Technology Company Information
  39. 6.7.2 Beijing Aitekang Medical Technology Business Overview
  40. 6.7.3 Beijing Aitekang Medical Technology Bio-based Hemostatic Powder Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Beijing Aitekang Medical Technology Bio-based Hemostatic Powder Product Portfolio
  42. 6.7.5 Beijing Aitekang Medical Technology Recent Developments
  43. 6.8 Baxter
  44. 6.8.1 Baxter Company Information
  45. 6.8.2 Baxter Business Overview
  46. 6.8.3 Baxter Bio-based Hemostatic Powder Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Baxter Bio-based Hemostatic Powder Product Portfolio
  48. 6.8.5 Baxter Recent Developments
  49. 6.9 Medtronic
  50. 6.9.1 Medtronic Company Information
  51. 6.9.2 Medtronic Business Overview
  52. 6.9.3 Medtronic Bio-based Hemostatic Powder Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Medtronic Bio-based Hemostatic Powder Product Portfolio
  54. 6.9.5 Medtronic Recent Developments
  55. 6.10 MedTrade Products
  56. 6.10.1 MedTrade Products Company Information
  57. 6.10.2 MedTrade Products Business Overview
  58. 6.10.3 MedTrade Products Bio-based Hemostatic Powder Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 MedTrade Products Bio-based Hemostatic Powder Product Portfolio
  60. 6.10.5 MedTrade Products Recent Developments
  61. 6.11 Hemostasis
  62. 6.11.1 Hemostasis Company Information
  63. 6.11.2 Hemostasis Business Overview
  64. 6.11.3 Hemostasis Bio-based Hemostatic Powder Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Hemostasis Bio-based Hemostatic Powder Product Portfolio
  66. 6.11.5 Hemostasis Recent Developments
  67. 6.12 BioCer Entwicklungs-GmbH
  68. 6.12.1 BioCer Entwicklungs-GmbH Company Information
  69. 6.12.2 BioCer Entwicklungs-GmbH Business Overview
  70. 6.12.3 BioCer Entwicklungs-GmbH Bio-based Hemostatic Powder Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 BioCer Entwicklungs-GmbH Bio-based Hemostatic Powder Product Portfolio
  72. 6.12.5 BioCer Entwicklungs-GmbH Recent Developments
7 North America by Country
  1. 7.1 North America Bio-based Hemostatic Powder Sales by Country
  2. 7.1.1 North America Bio-based Hemostatic Powder Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Bio-based Hemostatic Powder Sales by Country (2021-2026)
  4. 7.1.3 North America Bio-based Hemostatic Powder Sales Forecast by Country (2027-2032)
  5. 7.2 North America Bio-based Hemostatic Powder Market Size by Country
  6. 7.2.1 North America Bio-based Hemostatic Powder Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Bio-based Hemostatic Powder Market Size by Country (2021-2026)
  8. 7.2.3 North America Bio-based Hemostatic Powder Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Bio-based Hemostatic Powder Sales by Country
  2. 8.1.1 Europe Bio-based Hemostatic Powder Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Bio-based Hemostatic Powder Sales by Country (2021-2026)
  4. 8.1.3 Europe Bio-based Hemostatic Powder Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Bio-based Hemostatic Powder Market Size by Country
  6. 8.2.1 Europe Bio-based Hemostatic Powder Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Bio-based Hemostatic Powder Market Size by Country (2021-2026)
  8. 8.2.3 Europe Bio-based Hemostatic Powder Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Bio-based Hemostatic Powder Sales by Country
  2. 9.1.1 Asia-Pacific Bio-based Hemostatic Powder Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Bio-based Hemostatic Powder Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Bio-based Hemostatic Powder Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Bio-based Hemostatic Powder Market Size by Country
  6. 9.2.1 Asia-Pacific Bio-based Hemostatic Powder Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Bio-based Hemostatic Powder Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Bio-based Hemostatic Powder Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Bio-based Hemostatic Powder Sales by Country
  2. 10.1.1 South America Bio-based Hemostatic Powder Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Bio-based Hemostatic Powder Sales by Country (2021-2026)
  4. 10.1.3 South America Bio-based Hemostatic Powder Sales Forecast by Country (2027-2032)
  5. 10.2 South America Bio-based Hemostatic Powder Market Size by Country
  6. 10.2.1 South America Bio-based Hemostatic Powder Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Bio-based Hemostatic Powder Market Size by Country (2021-2026)
  8. 10.2.3 South America Bio-based Hemostatic Powder Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Bio-based Hemostatic Powder Sales by Country
  2. 11.1.1 Middle East and Africa Bio-based Hemostatic Powder Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Bio-based Hemostatic Powder Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Bio-based Hemostatic Powder Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Bio-based Hemostatic Powder Market Size by Country
  6. 11.2.1 Middle East and Africa Bio-based Hemostatic Powder Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Bio-based Hemostatic Powder Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Bio-based Hemostatic Powder Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Bio-based Hemostatic Powder Value Chain Analysis
  2. 12.1.1 Bio-based Hemostatic Powder Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Bio-based Hemostatic Powder Production Mode & Process
  7. 12.2 Bio-based Hemostatic Powder Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Bio-based Hemostatic Powder Distributors
  10. 12.2.3 Bio-based Hemostatic Powder Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst